Francis Knuettel II sold PTHS
May 22, 2026 · Form 4 insider transaction
Francis Knuettel II sold 1,500 shares of Pelthos Therapeutics Inc. at $26.84 per share, a transaction worth $40.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Represents an open market sale of the Lara Knuettel Revocable (the "Trust") on May 22, 2026. This transaction was executed in multiple trades at prices ranging from $26.66 to $27.16. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected; Francis Knuettel II is the co-trustee of the Trust and manager of Camden Capital LLC ("Camden"). By virtue of these relationships, Mr. Knuettel may be deemed to beneficially own the shares of Common Stock held of record by each of Camden and the Trust. Mr. Knuettel disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.